Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GON Block with Bupivacaine for Chronic Migraine
NCT02578719Phase 4Withdrawn
- Sponsor
- Yozgat Bozok University
- Start
- Jul 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of bupivacaine in chronic migraine, sponsored by Yozgat Bozok University. Planned start Jul 2016; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT02578719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02578719.